Heart, HIV drug maker Numerate acquires assets of Pharmix
See our story about this San Bruno, Calif., drug-engineering biotech at VentureBeat Life Sciences.
Next Story: Roundup: Microsoft gearing up for proxy battle, wiretapping, click-through study and more
Previous Story: Confirmed: Helio layoffs are happening
About the Author, David P. Hamilton
David Hamilton has been writing for VentureBeat LifeScience since April 2007. He formerly spent 14 years as a reporter for the Wall Street Journal in its San Francisco and Tokyo bureaus. Prior to that, he spent several years as a reporter at Science Magazine and as a reporter/researcher for the New Republic, both in Washington.